Quality of life in patients with relapsing multiple sclerosis taking intramuscular interferon beta-1a (Avonex®)

被引：0
作者：
Hyde, R.
Rudick, R. A.
Foulds, P.
You, X.
机构：
[1] Biogen Idec Int, Zug, Switzerland
[2] Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH USA
[3] Biogen Idec Inc, Cambridge, MA 02142 USA
来源：
JOURNAL OF NEUROLOGY | 2008年 / 255卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P455
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
[41]   ECONOMIC IMPLICATIONS OF REPLACING INTERFERON BETA-1A WITH OCRELIZUMAB IN RELAPSING MULTIPLE SCLEROSIS [J].
Thomas, N. ;
Ma, E. ;
Yu, E. B. .
VALUE IN HEALTH, 2017, 20 (05) :A191-A191
[42]   A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a [J].
Zivadinov, R ;
Zorzon, M ;
Tommasi, MA ;
Nasuelli, D ;
Bernardi, M ;
Monti-Bragadin, L ;
Cazzato, G .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 216 (01) :113-118
[43]   Interferon Beta-1a Modulation of B Cells: Implications for Relapsing Multiple Sclerosis [J].
Huang, Hui ;
Sumandeep, Sumandeep ;
Ito, Kouichi ;
Dhib-Jalbut, Suhayl .
NEUROLOGY, 2010, 74 (09) :A367-A367
[44]   Intramuscular abscess formation during Interferon-Beta-1a (Avonex) therapy for Multiple Sclerosis [J].
Greenstein, JI ;
Tobon, A .
NEUROLOGY, 2005, 64 (06) :A387-A387
[45]   Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis [J].
Fisher, E. ;
Nakamura, K. ;
Lee, J-C ;
You, X. ;
Sperling, B. ;
Rudick, R. A. .
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (05) :668-676
[46]   Final Results from the AVONEX® (Intramuscular Interferon Beta-1a) Pregnancy Exposure Registry [J].
Richman, Sandra ;
Wallace, Katrina ;
Liu, Shifang ;
Sperling, Bjorn .
NEUROLOGY, 2012, 78
[47]   Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosis [J].
Arroyo Gonzalez, Rafael ;
Kita, Mariko ;
Crayton, Heidi ;
Havrdova, Eva ;
Margolin, David H. ;
Lake, Stephen L. ;
Giovannoni, Gavin .
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (10) :1367-1376
[48]   No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study [J].
Kappos, Ludwig ;
Havrdova, Eva ;
Giovannoni, Gavin ;
Khatri, Bhupendra O. ;
Gauthier, Susan A. ;
Greenberg, Steven J. ;
You, Xiaojun ;
Wang, Ping ;
Giannattasio, Giorgio .
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (13) :1736-1747
[49]   Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study [J].
Bermel, R. A. ;
Weinstock-Guttman, B. ;
Bourdette, D. ;
Foulds, P. ;
You, X. ;
Rudick, R. A. .
MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (05) :588-596
[50]   Characteristics and clinical outcomes of underserved minority patients with multiple sclerosis treated with peginterferon beta-1a or intramuscular interferon beta-1a in MS PATHS [J].
Hersh, Carrie M. ;
Fitzgerald, Kathryn ;
Ryerson, Lana Zhovtis ;
Mowry, Ellen ;
Liao, Shirley ;
Altincatal, Arman ;
Naylor, Maria .
NEUROLOGY, 2021, 96 (15)
12345